|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DUALSTAR TECHNOLOGIES CORP, 10-Q, EX-10.19, 2000-11-14 |
Next: INKINE PHARMACEUTICAL CO INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-20-2001
<PERIOD-END> SEP-30-2000
<CASH> 8,147,063
<SECURITIES> 0
<RECEIVABLES> 1,974,661
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 23,622,246
<PP&E> 5,687,956
<DEPRECIATION> 0
<TOTAL-ASSETS> 33,651,071
<CURRENT-LIABILITIES> 10,501,540
<BONDS> 0
0
0
<COMMON> 164,988
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 33,651,071
<SALES> 1,848,962
<TOTAL-REVENUES> 1,848,962
<CGS> 1,189,381
<TOTAL-COSTS> 1,189,381
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 242,084
<INCOME-PRETAX> (3,640,208)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,640,208)
<DISCONTINUED> 232,667
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,407,541)
<EPS-BASIC> (0.21)
<EPS-DILUTED> (0.21)
</TABLE>
|
|